DL-01
DL-01 is a drug-linker conjugates for ADC that can be used for the synthesis of ADCs[1].
Product Specifications
CAS Number
2821770-49-2
UNSPSC
12352203
Hazard Statement
H302-H315-H319-H335
Target
Drug-Linker Conjugates for ADC
Type
ADC Related
Related Pathways
Antibody-drug Conjugate/ADC Related
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/dl-01.html
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CS(C1=NC=C(C=N1)C#CCCCC(N[C@@H](C(C)C)C(N[C@@H](CCCCN(CCC)CCC)C(NCC(NCOCCCC2=C3C(C(N4C3)=CC([C@](O)(C(OC5)=O)CC)=C5C4=O)=NC6=CC(OCO7)=C7C=C62)=O)=O)=O)=O)(=O)=O
Molecular Formula
C55H71N9O13S
Molecular Weight
1098.27
Precautions
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P330-P362+P364-P403+P233-P405-P501
References & Citations
[1]Yonghan Hu, et al. Antibody, antibody-drug conjugate thereof and use thereof. Patent WO2023046202A1.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, protect from light, stored under nitrogen)
Scientific Category
ADC Related
Clinical Information
No Development Reported
More Discoveries
Explore Other Products
Browse additional items from our catalog
RC201547L3V 200 µL
TPD52L2 (NM_003288) Human Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details 
